Metabolic Syndrome and Type 2 Diabetes/CVD Risk
- 1Key Points (1 page)
- 2IDF Clinical Criteria for Diagnosing the Metabolic Syndrome (1 page)
- 3Etiology and Treatment of the Metabolic Syndrome and its Components According to the IDF (3 pages)
- 4IDF Clinical Tools for Diagnosing the Metabolic Syndrome and Type 2 Diabetes/CVD Risk (3 pages)
- 5References (1 page)
- Waist girth is a mandatory feature of International IDF clinical criteria for diagnosing the metabolic syndrome.
- For the first time, population-specific cut-offs have been proposed to consider ethnic differences in the relationship between abdominal obesity and incidence of CHD and type 2 diabetes.
- IDF clinical criteria are similar to those proposed by the NCEP-ATP III regarding metabolic markers used to diagnose the metabolic syndrome.
- When managing the metabolic syndrome, the first step should be to reduce intra-abdominal (visceral) adipose tissue through lifestyle modification.
- Most prospective studies have found a positive relationship between the metabolic syndrome (IDF criteria) and CVD.
- Further research is required to establish specific waist circumference cut-offs for all regions of the world.